Emerging evidence supports the implementation of germline genetic counseling and testing as a key component of prostate cancer management. Further research is needed to elucidate the clinical significance of lesser known germline mutations and develop optimal screening, early detection and treatment paradigms in this patient population.
No takes yet. Share an insight, caveat, or question.
Das et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: